Drug Shortage Report for FOQUEST
Report ID | 145805 |
Drug Identification Number | 02470330 |
Brand name | FOQUEST |
Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 70MG |
Dosage form(s) | CAPSULE (CONTROLLED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2021-09-17 |
Actual start date | 2021-09-17 |
Estimated end date | 2021-09-30 |
Actual end date | 2021-09-27 |
Shortage status | Resolved |
Updated date | 2021-09-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-09-28 | English | Compare |
v5 | 2021-09-27 | French | Compare |
v4 | 2021-09-27 | English | Compare |
v3 | 2021-09-18 | English | Compare |
v2 | 2021-09-17 | French | Compare |
v1 | 2021-09-17 | English | Compare |
Showing 1 to 6 of 6